Anti-reflux medication use in preterm infants

BACKGROUND: Current recommendations do not support the use of anti-reflux medications to treat gastro-oesophageal reflux disease (GORD) among preterm infants. OBJECTIVE: To describe the prevalence of GORD and the use of anti-reflux medications amongst very preterm infants (<32 weeks’ gestational...

Descripción completa

Detalles Bibliográficos
Autores principales: Binti Abdul Hamid, Haslina, Szatkowski, Lisa, Budge, Helen, Ojha, Shalini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522583/
https://www.ncbi.nlm.nih.gov/pubmed/34716422
http://dx.doi.org/10.1038/s41390-021-01821-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522583/
https://www.ncbi.nlm.nih.gov/pubmed/34716422
http://dx.doi.org/10.1038/s41390-021-01821-y

Ejemplares similares